BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33684324)

  • 1. Self-reported Engagement in Care among U.S. Residents with Latent Tuberculosis Infection: 2011-2012.
    Mancuso JD; Miramontes R; Winston CA; Horsburgh CR; Hill AN
    Ann Am Thorac Soc; 2021 Oct; 18(10):1669-1676. PubMed ID: 33684324
    [No Abstract]   [Full Text] [Related]  

  • 2. Progress Toward Tuberculosis Elimination and Tuberculosis Program Performance - National Tuberculosis Indicators Project, 2016-2022.
    Woodruff R; Pratt R; Kolasa M
    MMWR Surveill Summ; 2024 Jun; 73(4):1-18. PubMed ID: 38833409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimated Latent Tuberculosis Infection Prevalence and Tuberculosis Reactivation Rates Among Non-U.S.-Born Residents in the United States, from the 2011-2012 National Health and Nutrition Examination Survey.
    Yelk Woodruff R; Hill A; Marks S; Navin T; Miramontes R
    J Immigr Minor Health; 2021 Aug; 23(4):806-812. PubMed ID: 32761297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity.
    Mirzazadeh A; Kahn JG; Haddad MB; Hill AN; Marks SM; Readhead A; Barry PM; Flood J; Mermin JH; Shete PB
    PLoS One; 2021; 16(4):e0249012. PubMed ID: 33793612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999-2000.
    Bennett DE; Courval JM; Onorato I; Agerton T; Gibson JD; Lambert L; McQuillan GM; Lewis B; Navin TR; Castro KG
    Am J Respir Crit Care Med; 2008 Feb; 177(3):348-55. PubMed ID: 17989346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Latent Tuberculosis Infection Among Non-US-Born Persons by Country of Birth-United States, 2012-2017.
    Collins JM; Stout JE; Ayers T; Hill AN; Katz DJ; Ho CS; Blumberg HM; Winglee K;
    Clin Infect Dis; 2021 Nov; 73(9):e3468-e3475. PubMed ID: 33137172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latent tuberculosis infection: Misperceptions among non-U.S.-born-populations from countries where tuberculosis is common.
    Parmer J; Macario E; Tatum K; Brackett A; Allen L; Picard R; DeLuca N; Dowling M
    Glob Public Health; 2022 Aug; 17(8):1728-1742. PubMed ID: 34228584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup.
    Shea KM; Kammerer JS; Winston CA; Navin TR; Horsburgh CR
    Am J Epidemiol; 2014 Jan; 179(2):216-25. PubMed ID: 24142915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis Testing and Latent Tuberculosis Infection Treatment Practices Among Health Care Providers - United States, 2020-2022.
    Caruso E; Mangan JM; Maiuri A; Bouwkamp B; DeLuca N
    MMWR Morb Mortal Wkly Rep; 2023 Nov; 72(44):1183-1189. PubMed ID: 37917562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interpreter usage and associations with latent tuberculosis infection treatment acceptance and completion in the USA among non-U.S.-born persons, 2012-2017.
    Gonzalez-Reyes R; Katz D; Lambert L; Sorri Y; Narita M; Horne DJ;
    PLoS One; 2024; 19(4):e0298628. PubMed ID: 38625902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between smoking and latent tuberculosis in the U.S. population: an analysis of the National Health and Nutrition Examination Survey.
    Horne DJ; Campo M; Ortiz JR; Oren E; Arentz M; Crothers K; Narita M
    PLoS One; 2012; 7(11):e49050. PubMed ID: 23145066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Programmatic impact of QuantiFERON-TB Gold In-Tube implementation on latent tuberculosis diagnosis and treatment in a public health clinic.
    Shah M; DiPietro D; Greenbaum A; Ketemepi S; Martins-Evora M; Marsiglia V; Dorman SE
    PLoS One; 2012; 7(5):e36551. PubMed ID: 22586476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimates of Testing for Latent Tuberculosis Infection and Cost, United States, 2013.
    Marks SM; Woodruff RY; Owusu-Edusei K; Asay GRB; Hill AN
    Public Health Rep; 2019; 134(5):522-527. PubMed ID: 31339816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trend and treatment outcomes of latent tuberculosis infection among migrant persons in Japan: retrospective analysis of Japan tuberculosis surveillance data.
    Kawatsu L; Uchimura K; Ohkado A
    BMC Infect Dis; 2021 Jan; 21(1):42. PubMed ID: 33422003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can Primary Care Drive Tuberculosis Elimination? Increasing Latent Tuberculosis Infection Testing and Treatment Initiation at a Community Health Center with a Large Non-U.S.-born Population.
    Tang AS; Mochizuki T; Dong Z; Flood J; Katrak SS
    J Immigr Minor Health; 2023 Aug; 25(4):803-815. PubMed ID: 36652151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of latent tuberculosis treatment initiation and completion at a U.S. public health clinic: a prospective cohort study.
    Goswami ND; Gadkowski LB; Piedrahita C; Bissette D; Ahearn MA; Blain ML; Østbye T; Saukkonen J; Stout JE
    BMC Public Health; 2012 Jun; 12():468. PubMed ID: 22720842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis among Newly Arrived Immigrants and Refugees in the United States.
    Liu Y; Phares CR; Posey DL; Maloney SA; Cain KP; Weinberg MS; Schmit KM; Marano N; Cetron MS
    Ann Am Thorac Soc; 2020 Nov; 17(11):1401-1412. PubMed ID: 32730094
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-effectiveness of Testing and Treatment for Latent Tuberculosis Infection in Residents Born Outside the United States With and Without Medical Comorbidities in a Simulation Model.
    Tasillo A; Salomon JA; Trikalinos TA; Horsburgh CR; Marks SM; Linas BP
    JAMA Intern Med; 2017 Dec; 177(12):1755-1764. PubMed ID: 29049814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The paradigm shift in the approach to management of latent tuberculosis infection in high tuberculosis burden countries.
    Padmapriyadarsini C; Sachdeva KS; Nair D; Ramachandran R
    Expert Rev Respir Med; 2021 Jul; 15(7):899-910. PubMed ID: 33302729
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of latent tuberculosis infection in China: Exploring solutions suitable for high-burden countries.
    Cui X; Gao L; Cao B
    Int J Infect Dis; 2020 Mar; 92S():S37-S40. PubMed ID: 32114201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.